Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells | BMC Cancer | Full Text

Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells | BMC Cancer | Full Text

Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells

The skeleton is the first and most common distant metastatic site for breast cancer. Such metastases complicate cancer management, inducing considerable morbidities and decreasing patient survival. Osteomimeti...

Authors:L. Absil, F. Journé, D. Larsimont, J. J. Body, L. Tafforeau and D. Nonclercq

Citation:BMC Cancer 2020 20:640

Content type:Research article

 

Published on: 10 July 2020

• ViewFull Text
 
• ViewPDF